Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Abroad (travel likely)RecruitingPHASE1

Conditions

Nonalcoholic Steatohepatitis (NASH) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) · Non-alcoholic Fatty Liver Disease (NAFLD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Missouri, Columbia, Missouri, United States
Contact: Study coordinator (Elizabeth Parks, PhD) · parksej@missouri.edu · 573-882-5864
Contact: Study coordinator (Jessica George, BS) · jgmft7@mail.missouri.edu · (573) 884-2014

Study leads

Kavita Juneja, MD
Study Director
Corcept Therapeutics

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Nonalcoholic Fatty Liver Disease · Nonalcoholic Fatty Liver Disease (NAFLD) · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Abroad (travel likely)Recruiting

Nottingham, United Kingdom · Nottingham, United Kingdom

NAC- NAFLD And Cushing

Cushing Syndrome · Fatty Liver Disease

Abroad (travel likely)Recruiting

Angers, France · Bordeaux, France

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis · Fibrosis

Abroad (travel likely)Recruiting

Beijing, China

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD

Abroad (travel likely)RecruitingPHASE2

Richmond, United States